BRIEF published on 11/20/2024 at 15:35, 19 hours 23 minutes ago Symrise AG Unveils Strategic Growth Plans at Capital Market Day Sustainability Goals Digitalization Growth Outlook Capital Market Day Symrise Strategy
PRESS RELEASE published on 11/20/2024 at 15:30, 19 hours 28 minutes ago Symrise Capital Market Day: Unleashing the full beauty of ONE Symrise, being and staying unique Symrise AG hosts successful Capital Market Day unveiling ONE Symrise strategy for sustainable growth and enhanced profitability under new CEO Jean-Yves Parisot Profitability Sustainable Growth Symrise AG Capital Market Day ONE Symrise
BRIEF published on 10/24/2024 at 07:35, 28 days 3 hours ago Symrise Reports Continued Profitable Growth in 2024 Profitable Growth Regional Growth Organic Sales Increase Taste & Nutrition Scent & Care
PRESS RELEASE published on 10/24/2024 at 07:30, 28 days 3 hours ago Symrise continues strong profitable growth course Symrise AG reports 11.1% organic sales growth in first nine months of 2024, reaffirms 7% organic sales target for full year Business Development Organic Sales Growth Profitable Growth Symrise AG 2024 Financial Results
BRIEF published on 09/12/2024 at 14:08, 2 months 8 days ago Executive Board of Symrise AG Reorganized Leadership Changes Executive Board Symrise AG Walter Ribeiro Jörn Andreas
PRESS RELEASE published on 09/12/2024 at 14:03, 2 months 8 days ago Executive Board of Symrise AG reorganized Symrise AG reorganizes Executive Board with Walter Ribeiro appointed for Taste, Nutrition & Health. Jörn Andreas leaves. Jean-Yves Parisot interim head of Scent & Care segment Executive Board Reorganization Symrise AG Walter Ribeiro Jörn Andreas
BRIEF published on 08/01/2024 at 07:35, 3 months 20 days ago Symrise Reports Q1 2024 Profitable Growth Despite Global Challenges Financial Results EBITDA Margin Organic Sales Growth Profitable Growth Symrise AG
PRESS RELEASE published on 08/01/2024 at 07:30, 3 months 20 days ago Symrise on a profitable growth course in a challenging environment Symrise AG reports 6.3% sales increase and higher profitability in H1 2024. Targets 5-7% organic growth in 2024 with 20% EBITDA margin Profitability EBITDA Margin Sales Increase Growth Targets Symrise AG
BRIEF published on 04/25/2024 at 07:35, 6 months 26 days ago Symrise Reports Strong Start to 2024 with Enhanced Sales and Growth Projections Organic Sales Growth Symrise AG 2024 Financial Growth Scent And Care Division EBITDA Targets
PRESS RELEASE published on 04/25/2024 at 07:30, 6 months 26 days ago Symrise sees successful start into the 2024 fiscal year Symrise AG reports successful start in 2024 fiscal year with 10.9% organic growth and €1.3 billion in group sales for Q1. Targets through 2028 confirmed Organic Growth Sales Increase Symrise AG 2024 Fiscal Year Long-term Targets
Published on 11/21/2024 at 10:03, 55 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 58 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 58 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 23 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 33 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 27 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 53 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 55 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 57 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 57 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 4 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 38 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 13 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 13 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
